Caribou Biosciences (CRBU) Competitors $1.25 -0.01 (-0.79%) Closing price 04:00 PM EasternExtended Trading$1.25 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRBU vs. ATAI, ZVRA, TYRA, MAZE, VALN, SEPN, ATYR, MREO, CGEM, and AMLXShould you be buying Caribou Biosciences stock or one of its competitors? The main competitors of Caribou Biosciences include atai Life Sciences (ATAI), Zevra Therapeutics (ZVRA), Tyra Biosciences (TYRA), Maze Therapeutics (MAZE), Valneva (VALN), Septerna (SEPN), aTyr Pharma (ATYR), Mereo BioPharma Group (MREO), Cullinan Therapeutics (CGEM), and Amylyx Pharmaceuticals (AMLX). These companies are all part of the "pharmaceutical products" industry. Caribou Biosciences vs. Its Competitors atai Life Sciences Zevra Therapeutics Tyra Biosciences Maze Therapeutics Valneva Septerna aTyr Pharma Mereo BioPharma Group Cullinan Therapeutics Amylyx Pharmaceuticals atai Life Sciences (NASDAQ:ATAI) and Caribou Biosciences (NASDAQ:CRBU) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations, dividends and media sentiment. Which has higher earnings & valuation, ATAI or CRBU? Caribou Biosciences has higher revenue and earnings than atai Life Sciences. atai Life Sciences is trading at a lower price-to-earnings ratio than Caribou Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioatai Life Sciences$310K1,751.36-$149.27M-$0.91-2.98Caribou Biosciences$9.99M11.64-$149.10M-$1.62-0.77 Is ATAI or CRBU more profitable? atai Life Sciences has a net margin of 0.00% compared to Caribou Biosciences' net margin of -1,490.84%. Caribou Biosciences' return on equity of -55.70% beat atai Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets atai Life SciencesN/A -102.10% -77.55% Caribou Biosciences -1,490.84%-55.70%-45.35% Do analysts recommend ATAI or CRBU? atai Life Sciences currently has a consensus price target of $8.67, indicating a potential upside of 219.80%. Caribou Biosciences has a consensus price target of $8.50, indicating a potential upside of 580.00%. Given Caribou Biosciences' higher possible upside, analysts plainly believe Caribou Biosciences is more favorable than atai Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score atai Life Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Caribou Biosciences 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, ATAI or CRBU? atai Life Sciences has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Comparatively, Caribou Biosciences has a beta of 2.44, suggesting that its share price is 144% more volatile than the S&P 500. Does the media prefer ATAI or CRBU? In the previous week, atai Life Sciences had 13 more articles in the media than Caribou Biosciences. MarketBeat recorded 15 mentions for atai Life Sciences and 2 mentions for Caribou Biosciences. Caribou Biosciences' average media sentiment score of 0.93 beat atai Life Sciences' score of 0.10 indicating that Caribou Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment atai Life Sciences 3 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Caribou Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in ATAI or CRBU? 28.4% of atai Life Sciences shares are owned by institutional investors. Comparatively, 77.5% of Caribou Biosciences shares are owned by institutional investors. 26.8% of atai Life Sciences shares are owned by company insiders. Comparatively, 9.5% of Caribou Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryCaribou Biosciences beats atai Life Sciences on 10 of the 17 factors compared between the two stocks. Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRBU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRBU vs. The Competition Export to ExcelMetricCaribou BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$116.25M$2.87B$5.52B$8.86BDividend YieldN/A2.70%5.36%4.13%P/E Ratio-0.7721.1926.3919.77Price / Sales11.64264.39408.83110.45Price / CashN/A41.2925.8827.49Price / Book0.457.237.915.36Net Income-$149.10M-$55.05M$3.15B$248.34M7 Day Performance-11.35%-0.58%1.04%1.28%1 Month Performance16.28%6.50%5.36%5.45%1 Year Performance-21.38%0.22%32.71%18.02% Caribou Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRBUCaribou Biosciences2.0803 of 5 stars$1.25-0.8%$8.50+580.0%-23.2%$116.25M$9.99M-0.77100ATAIatai Life Sciences3.0084 of 5 stars$2.02-18.5%$8.67+329.0%+64.7%$496.84M$310K-2.2280Trending NewsOptions VolumeGap UpHigh Trading VolumeZVRAZevra Therapeutics2.7297 of 5 stars$9.00-0.4%$22.29+147.6%+79.8%$494.30M$23.61M-4.7420Positive NewsTYRATyra Biosciences2.0075 of 5 stars$9.71+5.2%$30.83+217.5%-40.2%$490.02MN/A-5.9620News CoverageAnalyst ForecastMAZEMaze TherapeuticsN/A$10.73-4.0%$25.67+139.2%N/A$489.65M$167.50M0.00121Positive NewsVALNValneva2.0224 of 5 stars$5.56-1.1%$15.50+178.8%-19.1%$478.23M$183.52M-4.67700Positive NewsSEPNSepterna1.897 of 5 stars$10.53+0.6%$26.75+154.0%N/A$466.53M$1.08M0.00N/APositive NewsATYRaTyr Pharma2.7528 of 5 stars$4.98-4.6%$20.20+305.6%N/A$464.60M$230K-6.1553High Trading VolumeMREOMereo BioPharma Group2.2262 of 5 stars$2.74-3.9%$7.60+177.4%-24.7%$453.15M$10M-39.1440CGEMCullinan Therapeutics2.233 of 5 stars$7.58-1.2%$30.00+295.8%-56.8%$452.64MN/A-2.6030Positive NewsAMLXAmylyx Pharmaceuticals3.5011 of 5 stars$5.02-0.6%$10.14+102.0%+237.4%$450.16M$87.37M-1.61200 Related Companies and Tools Related Companies atai Life Sciences Competitors Zevra Therapeutics Competitors Tyra Biosciences Competitors Maze Therapeutics Competitors Valneva Competitors Septerna Competitors aTyr Pharma Competitors Mereo BioPharma Group Competitors Cullinan Therapeutics Competitors Amylyx Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRBU) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caribou Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caribou Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
